ESC 2020: Commentary on the DAPA-CKD Study — Dr Giuseppe Galati
- Видео
- О видео
- Скачать
- Поделиться
ESC 2020: Commentary on the DAPA-CKD Study — Dr Giuseppe Galati
Dr Giuseppe Galati (San Raffaele Scientific Institute, Milan, IT) discusses the DAPA-CKD study that was presented at ESC 2020. This study evaluated the effect of dapagliflozin on renal outcomes and cardiovascular mortality in patients with chronic kidney disease. Recorded remotely from Milan, 2020. Recording Editor: Natascha Wienand Editor: Mirjam Boros
286 | 4 год. назад | 0 - 0
Dr Giuseppe Galati (San Raffaele Scientific Institute, Milan, IT) discusses the DAPA-CKD study that was presented at ESC 2020.
This study evaluated the effect of dapagliflozin on renal outcomes and cardiovascular mortality in patients with chronic kidney disease.
Recorded remotely from Milan, 2020.
Recording Editor: Natascha Wienand
Editor: Mirjam Boros
Чтобы скачать видео "ESC 2020: Commentary on the DAPA-CKD Study — Dr Giuseppe Galati" передвинте ползунок вправо
- Комментарии
Комментарии ФБ